Skip to Content

Betoptic S Dosage

Generic name: Betaxolol Hydrochloride 2.8mg in 1mL
Dosage form: ophthalmic suspension

See also:

Betoptic ophthalmic solution

Medically reviewed on March 22, 2017.

Instill one drop of BETOPTIC S Ophthalmic Suspension 0.25% in the affected eye(s) twice daily. BETOPTIC S may be used alone or in combination with other IOP lowering medications.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Betoptic S (betaxolol ophthalmic)

Consumer resources

Professional resources

Other Formulations

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

WADA Class Anti-Doping Classification

Manufacturer

Novartis Pharmaceuticals Corporation

Drug Class

Ophthalmic glaucoma agents

Related Drugs

Glaucoma, Open Angle timolol ophthalmic, epinephrine ophthalmic, Lumigan, latanoprost ophthalmic, brimonidine ophthalmic, Xalatan, Travatan, pilocarpine ophthalmic, Cosopt, Azopt, Alphagan, dorzolamide ophthalmic, More...

Intraocular Hypertension timolol ophthalmic, Lumigan, latanoprost ophthalmic, brimonidine ophthalmic, Xalatan, Travatan, pilocarpine ophthalmic, Combigan, Cosopt, Azopt, Alphagan, dorzolamide ophthalmic, More...

Betoptic S Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.